Safety and efficacy of GABAergic medications for treating alcoholism.
This article highlights the proceedings of a symposium presented at the 27th Annual Scientific Meeting of the Research Society on Alcoholism in Vancouver, British Columbia, Canada, June 29, 2004. The organizers and co-chairs were Bankole A. Johnson, MD, PhD, and Robert M. Swift, MD, PhD. The presentations included (1) Introduction, by Bankole A. Johnson; (2) Safety, Tolerability, and Efficacy of gamma-Hydroxybutyric Acid and Baclofen in the Treatment of Alcohol Addiction, by Giovanni Addolorato; (3) Safety of Gabapentin in Treating Alcoholism, by Hugh Myrick; (4) New Data on the Safety and Effectiveness of Topiramate in the Treatment of Alcohol Dependence, by Bankole A. Johnson; (5) Evaluating the Risk of Benzodiazepine Prescription to Alcohol-Dependent Individuals, by Domenic A. Ciraulo; and (6) Safety and Efficacy of GABAergic Agents in Treating Alcoholics: Discussion, by Robert M. Swift.
Johnson
Bankole A
BA
Department of Psychiatric Medicine, The University of Virginia, Charlottesville, Virginia 22908-0623, USA. bankolejohnson@virginia.edu
Swift
Robert M
RM
Addolorato
Giovanni
G
Ciraulo
Domenic A
DA
Myrick
Hugh
H
D000437:Alcoholism / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D018682:GABA Agents / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans
D018682:GABA Agents